Cargando…

Differential Expression of Human Peripheral Mononuclear Cells Phenotype Markers in Type 2 Diabetic Patients and Type 2 Diabetic Patients on Metformin

Background: Although peripheral blood mononuclear cells (PBMC) have been demonstrated to be in a pro-inflammatory state in obesity and type 2 Diabetes Mellitus (T2DM), characterization of circulating PBMC phenotypes in the obese and T2DM and the effect of Metformin on these phenotypes in humans is s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al Dubayee, Mohammed S., Alayed, Hind, Almansour, Rana, Alqaoud, Nora, Alnamlah, Rahaf, Obeid, Dana, Alshahrani, Awad, Zahra, Mahmoud M., Nasr, Amre, Al-Bawab, Ahmad, Aljada, Ahmad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6189318/ https://www.ncbi.nlm.nih.gov/pubmed/30356719 http://dx.doi.org/10.3389/fendo.2018.00537

Ejemplares similares

Gene Expression Profiling of Peripheral Blood Mononuclear Cells in Type 2 Diabetes: An Exploratory Study
por: Fakhoury, Hana M. A., et al.
Publicado: (2022)

Gene Expression Profiling of Apoptotic Proteins in Circulating Peripheral Blood Mononuclear Cells in Type II Diabetes Mellitus and Modulation by Metformin
por: Al Dubayee, Mohammed, et al.
Publicado: (2021)

Obesity Connected Metabolic Changes in Type 2 Diabetic Patients Treated With Metformin
por: Aleidi, Shereen M., et al.
Publicado: (2021)

Distinctive Metabolomics Patterns Associated With Insulin Resistance and Type 2 Diabetes Mellitus
por: Gu, Xinyun, et al.
Publicado: (2020)

Proteomic Profiling Identifies Distinct Regulation of Proteins in Obese Diabetic Patients Treated with Metformin
por: Alshahrani, Awad, et al.
Publicado: (2023)

Phenotypic Characterization of Human Monocytes following Macronutrient Intake in Healthy Humans
por: Alshahrani, Awad, et al.
Publicado: (2017)

Altered Sirtuin 7 Expression is Associated with Early Stage Breast Cancer
por: Aljada, Ahmad, et al.
Publicado: (2015)

Differential Expression of Human N-Alpha-Acetyltransferase 40 (hNAA40), Nicotinamide Phosphoribosyltransferase (NAMPT) and Sirtuin-1 (SIRT-1) Pathway in Obesity and T2DM: Modulation by Metformin and Macronutrient Intake
por: Alshahrani, Awad, et al.
Publicado: (2019)

Significant differences in FcγRIIa, FcγRIIIa and FcγRIIIb genes polymorphism and anti-malarial IgG subclass pattern are associated with severe Plasmodium falciparum malaria in Saudi children
por: Nasr, Amre, et al.
Publicado: (2021)

Correlation analysis between cytokines’ profile, autoimmune antibodies and the duration of type 1 diabetes: A case control study in a specialized children’s centre in Riyadh
por: Al-Dubayee, Mohammed, et al.
Publicado: (2023)

In vitro cytotoxicity of Artemisia vulgaris L. essential oil is mediated by a mitochondria-dependent apoptosis in HL-60 leukemic cell line
por: Saleh, Ayman M, et al.
Publicado: (2014)

Metformin modulates mitochondrial function and mitophagy in peripheral blood mononuclear cells from type 2 diabetic patients
por: de Marañón, Aranzazu M., et al.
Publicado: (2022)

Validation of the Survival Benefits of Metformin in Middle Eastern Patients With Type II Diabetes Mellitus and Colorectal Cancer
por: Al Omari, Amal, et al.
Publicado: (2018)

Metformin and Cancer in Type 2 Diabetes
por: Park, Hyeong Kyu
Publicado: (2013)

Metformin and Type 2 Diabetes Prevention
por: Aroda, Vanita R., et al.
Publicado: (2018)

Diabetic Nephropathy and Its Risk Factors in a Society with a Type 2 Diabetes Epidemic: A Saudi National Diabetes Registry-Based Study
por: Al-Rubeaan, Khalid, et al.
Publicado: (2014)

Association of Metformin Treatment with Reduced Severity of Diabetic Retinopathy in Type 2 Diabetic Patients
por: Li, Yue, et al.
Publicado: (2018)

Vitamin B12 Deficiency and Clinical Neuropathy with Metformin Use in Type 2 Diabetes
por: Farooq, Malik Dilaver, et al.
Publicado: (2022)

A Review of the Impact of Pharmacogenetics and Metabolomics on the Efficacy of Metformin in Type 2 Diabetes
por: Damanhouri, Zoheir A., et al.
Publicado: (2023)

Where Does Metformin Stand in Modern Day Management of Type 2 Diabetes?
por: Ahmad, Ehtasham, et al.
Publicado: (2020)

The effects of metformin in type 1 diabetes mellitus
por: Beysel, Selvihan, et al.
Publicado: (2018)

Vildagliptin efficacy in combination with metformin among Jordanian patients with type 2 diabetes mellitus inadequately controlled with metformin
por: Al Omari, Mousa, et al.
Publicado: (2016)

The Impact of Insulin Staging in the Context of Pharmaceutical Care on Patients with Type 2 Diabetes Mellitus
por: Obeid, Kawa Ahmad, et al.
Publicado: (2023)

Quality of Life and Glycemic Control in Saudi Children with Type 1 Diabetes at Different Developmental Age Groups
por: Babiker, Amir, et al.
Publicado: (2021)

Prevalence of obesity and overweight among type 2 diabetic patients in Bisha, Saudi Arabia
por: AlShahrani, Mohammad S.
Publicado: (2021)

Comparison of Vildagliptin-Metformin and Glimepiride-Metformin Treatments in Type 2 Diabetic Patients
por: Jeon, Hyun Jeong, et al.
Publicado: (2011)

Influence of metformin intake on serum vitamin B12 levels in patients with type 2 diabetes mellitus
por: Al-Fawaeir, Saad, et al.
Publicado: (2022)

Metformin and/or vildagliptin mitigate type II diabetes mellitus induced-oxidative stress: The intriguing effect
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2020)

Antidepressants and type 2 diabetes: highways to knowns and unknowns
por: Alruwaili, Nahi Sabih, et al.
Publicado: (2023)

Effects of metformin on endothelial function in type 2 diabetes
por: WU, SONGLIN, et al.
Publicado: (2014)

Metformin and the Risk of Dementia in Type 2 Diabetes Patients
por: Chin-Hsiao, Tseng
Publicado: (2019)

Role of Metformin on Osteoblast Differentiation in Type 2 Diabetes
por: Jiating, Lin, et al.
Publicado: (2019)

Metformin and the Development of Asthma in Patients with Type 2 Diabetes
por: Yen, Fu-Shun, et al.
Publicado: (2022)

The use of metformin for type 2 diabetes prevention: Observational multicenter study from Saudi Arabia
por: Alfayez, Osamah M., et al.
Publicado: (2022)

Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?
por: Dzięgielewska-Gęsiak, Sylwia, et al.
Publicado: (2022)

Optimising the medical management of hyperglycaemia in type 2 diabetes in the Middle East: pivotal role of metformin
por: Al-Maatouq, M, et al.
Publicado: (2009)

Pharmacometabolomic Approach to Investigate the Response to Metformin in Patients with Type 2 Diabetes: A Cross-Sectional Study
por: Naja, Khaled, et al.
Publicado: (2023)

Comparative evaluation of biphasic insulin with metformin and triple oral hypoglycemic agents (OHA) in type 2 diabetes patients
por: Alavudeen, Sirajudeen Shaik, et al.
Publicado: (2020)

Patient-factors associated with metformin steady-state levels in type 2 diabetes mellitus with therapeutic dosage
por: Ningrum, Vitarani D.A., et al.
Publicado: (2018)

Fixed combination of repaglinide and metformin in the management of type 2 diabetes
por: Moses, Robert
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_2hv5ujkbo4stu2s0cvapqlt5mj